I’d like to introduce a new type of anticancer drugs—epigenetic drugs here today, which are a new area that has arisen in the medical world in recent years.
Let’s first see what epigenetics is before knowing the drugs. Epigenetics was coined by Conrad Waddington, a British developmental biologist, in the 1950s to describe the interactions between the environment and the genes in the developmental process, which regulate and decide the ultimate fates of the tissue and organs. Epigenetics mainly studies the heritable changes in gene expression without a change in the nucleotide sequence.
